Adenocortical carcinoma: A rare malignant tumor
1 Department of Urology, Hassan II University Hospital, Fez, Morocco.
2 Faculty of Medicine, Pharmacy and Dentistry of Fez, Sidi Mohammed Ben Abdellah University, Fez, Morocco.
Case Study
World Journal of Advanced Research and Reviews, 2024, 21(02), 1430–1434
Publication history:
Received on 22 January 2024; revised on 19 February 2024; accepted on 21 February 2024
Abstract:
Adrenocortical adenocarcinoma (ACA) is a rare malignancy that develops at the expense of the adrenal cortex. The key to its treatment lies in surgery, with complete resection of a localized form offering the best chance of cure. This article presents the case of a 68-year-old man treated for adrenocortical adenocarcinoma at the Hassan 2 University Hospital in Fez. The patient, with no notable pathological history, consulted for dizziness and abdominal pain, leading to the discovery of a malignant adrenal mass on radiological evaluation. A successful left laparotomy adrenalectomy was performed, confirming, by pathological analysis, a Weiss score 4 adenocarcinoma. Immunohistochemical results showed expression of cytokeratin AE1/AE3, while other markers were absent. The article highlights the efficacy of surgery in the treatment of localized forms of this rare tumor, while highlighting diagnostic challenges and the need for international coordination in adrenocortical adenocarcinoma research and care.
Keywords:
Adenocortical Carcinoma; Case Report; Malignant Tumor; Adrenal Cortex; Surgery; Laparotomy
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0